Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Cash from Operating Activities
Meridian Bioscience Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Cash from Operating Activities
$82.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Operating Activities
$563.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Operating Activities
$423m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Operating Activities
$785.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Operating Activities
$324m
|
CAGR 3-Years
168%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's Cash from Operating Activities?
Cash from Operating Activities
82.4m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Cash from Operating Activities amounts to 82.4m USD.
What is Meridian Bioscience Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
15%
Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for Meridian Bioscience Inc have been 32% over the past three years , 15% over the past five years .